Cargando…

The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration

Many pathological conditions are associated with phosphatidylinositol 3-kinase (PI3K) dysfunction, providing an incentive for the study of the effects of PI3K modulation in different aspects of diabetes, cancer, and aging. The PI3K/AKT/mTOR pathway is a key transducer of brain metabolic and mitogeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heras-Sandoval, David, Avila-Muñoz, Evangelina, Arias, Clorinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058660/ http://dx.doi.org/10.3390/ph4081070

Ejemplares similares

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
por: Martelli, Alberto M., et al.
Publicado: (2010)

Dendrite pathology and neurodegeneration: focus on mTOR
por: Di Polo, Adriana
Publicado: (2015)

Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
por: Hayashi, Takahiro, et al.
Publicado: (2023)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014)

Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma
por: Graf, Nicolas, et al.
Publicado: (2014)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012)

Phosphatidylinositol 3'-kinase, mTOR, and Glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells
por: Yohn, Nicole L, et al.
Publicado: (2011)

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
por: Elfiky, Aymen A, et al.
Publicado: (2011)

Role of Wnt Signaling in the Control of Adult Hippocampal Functioning in Health and Disease: Therapeutic Implications
por: Ortiz-Matamoros, Abril, et al.
Publicado: (2013)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1
por: Maiese, Kenneth
Publicado: (2020)

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
por: Wanigasooriya, Kasun, et al.
Publicado: (2020)

Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2020)

mTOR pathway – a potential therapeutic target in stroke
por: Melanis, Konstantinos, et al.
Publicado: (2023)

The mTOR-S6 kinase pathway promotes stress granule assembly
por: Sfakianos, Aristeidis P., et al.
Publicado: (2018)

mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses
por: Huynh, HoangDinh, et al.
Publicado: (2021)

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

mTOR Pathways in Cancer and Autophagy
por: Paquette, Mathieu, et al.
Publicado: (2018)

The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022)

Correction to: The mTOR-S6 kinase pathway promotes stress granule assembly
por: Sfakianos, Aristeidis P., et al.
Publicado: (2019)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration
por: Salcedo-Tello, Pamela, et al.
Publicado: (2011)

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Anesthetics disrupt brain development via actions on the mTOR pathway
por: Xu, Jing, et al.
Publicado: (2018)

Roles of mTOR Signaling in Brain Development
por: Lee, Da Yong
Publicado: (2015)

mTOR-Dependent Cell Proliferation in the Brain
por: Ryskalin, Larisa, et al.
Publicado: (2017)

Telomerase and mTOR in the brain: the mitochondria connection
por: Miwa, Satomi, et al.
Publicado: (2017)

The mTOR Signalling Pathway in Human Cancer
por: Pópulo, Helena, et al.
Publicado: (2012)

mTOR pathway in colorectal cancer: an update
por: Francipane, Maria Giovanna, et al.
Publicado: (2013)

Harnessing the mTOR Pathway for Tuberculosis Treatment
por: Singh, Pooja, et al.
Publicado: (2018)

mTOR pathway in familial focal epilepsies
por: Ribierre, Théo, et al.
Publicado: (2016)

The role of the mTOR pathway in diabetic retinopathy
por: Casciano, Fabio, et al.
Publicado: (2022)

The mTOR signaling pathway in cardiac aging
por: Dai, Dao-Fu, et al.
Publicado: (2023)

BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain—Implications for Neurodegeneration
por: Lanzillotta, Chiara, et al.
Publicado: (2020)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020)

Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
por: Chen, Lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mmfho2nli84f4qj5itcikeoda5